Glucotrack, Inc. Files 8-K
Ticker: GCTK · Form: 8-K · Filed: Apr 3, 2025 · CIK: 1506983
Sentiment: neutral
Topics: regulatory-filing, financial-reporting
TL;DR
Glucotrack filed a routine 8-K on 4/3/25. Check exhibits for news.
AI Summary
Glucotrack, Inc. filed an 8-K on April 3, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Integrity Applications, Inc., is incorporated in Delaware and headquartered in Rutherford, NJ. This filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates Glucotrack, Inc. is meeting its regulatory reporting obligations. Investors should review the exhibits for any material updates.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting purposes and does not disclose any new material risks or events.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- Integrity Applications, Inc. (company) — Former company name
- April 3, 2025 (date) — Date of report
- Rutherford, NJ (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Glucotrack, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits, as of April 3, 2025.
When was Glucotrack, Inc. formerly known as Integrity Applications, Inc.?
Glucotrack, Inc. was formerly known as Integrity Applications, Inc. until December 3, 2010.
What is the state of incorporation for Glucotrack, Inc.?
Glucotrack, Inc. is incorporated in Delaware.
Where are Glucotrack, Inc.'s principal executive offices located?
Glucotrack, Inc.'s principal executive offices are located at 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.
What is the SIC code for Glucotrack, Inc.?
The Standard Industrial Classification (SIC) code for Glucotrack, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 3, 2025 regarding Glucotrack, Inc. (GCTK).